Novavax, a small US drug maker, is relatively unknown. But their first-ever vaccine—for COVID-19—proved as effective as big-name competitors in a UK trial. The company is preparing to file for authorization in the US and India. South Korea is already aiming for local…

Children make up a rising portion of new US COVID-19 cases–reaching nearly 21% last week, the

New research delivers troubling signs that drug-resistant mutations in a malaria parasite may be gaining traction in Rwanda, 

One possibility: US regulators could follow the lead of Europe, which limited the AstraZeneca vaccine to certain age groups; or it may add cautionary clauses,

Ravaged by new surges, Brazil is now the pandemic’s epicenter as daily deaths top 3,000 and the health system is collapsing,

Mounting research has shown pregnant women fare worse than their nonpregnant counterparts when it comes to COVID-19.   One promising finding is that the virus rarely crosses over to the fetus.

Some long-haul COVID-19 patients are reporting post-jab improvements.

A decade after the start of the Syrian civil war, a “Syrian PTSD crisis” has taken hold, according to a 

Superspreader events have long been recognized as a key player in this pandemic.  

Children—who have largely been spared from the worst effects of COVID-19—are at the back of the vaccine line,